Furui Medical Technology (01696) announced interim results with loss attributable to parent company owners of $1.155 million year-on-year profit to loss

According to the Zhitong Finance App, FuRui Medical Technology (01696) announced its 2026 interim results, with revenue of approximately US$171.4 million, an increase of 3.6% over the previous year. The owner of the parent company should have accounted for a loss of US$1.155 million, a year-on-year profit to loss; loss of 0.25 US cents per share.